Skip to main content

Brompheniramine / carbetapentane / phenylephrine Pregnancy and Breastfeeding Warnings

Brand names: BetaTan, Pulmari, Seradex, Trexbrom (old formulation), V-COF, Vazotan

Brompheniramine / carbetapentane / phenylephrine Pregnancy Warnings

Brompheniramine/carbetapentane/phenylephrine has been assigned to pregnancy category C by the FDA. Animal studies have not been reported. There are no controlled data in human pregnancy. Brompheniramine/carbetapentane/phenylephrine is only recommended for use during pregnancy when benefit outweighs risk.

See references

Brompheniramine / carbetapentane / phenylephrine Breastfeeding Warnings

There are no data on the excretion of brompheniramine/carbetapentane/phenylephrine into human milk. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

See references

References for pregnancy information

  1. (2005) "Product Information. BetaTan (brompheniramine/carbetapentane/phenylephrine)." WraSer Pharmaceuticals

References for breastfeeding information

  1. (2005) "Product Information. BetaTan (brompheniramine/carbetapentane/phenylephrine)." WraSer Pharmaceuticals

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer